Advancements in therapeutic approaches for malignant peripheral nerve sheath tumor

Elena Millesi; Julian S Rechberger; Huan Wang; Samir Mardini; Robert J Spinner; David J Daniels

doi:10.4155/tde-2023-0014

Advancements in therapeutic approaches for malignant peripheral nerve sheath tumor

Ther Deliv. 2023 Jun;14(6):385-389. doi: 10.4155/tde-2023-0014. Epub 2023 Jul 18.

Authors

Elena Millesi^{1

2}, Julian S Rechberger^{3

4}, Huan Wang³, Samir Mardini¹, Robert J Spinner³, David J Daniels^{3

4}

Affiliations

¹ Division of Plastic & Reconstructive Surgery, Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA.
² Research Laboratory of the Division of Plastic & Reconstructive Surgery, Department of Surgery, Medical University of Vienna, Vienna, 1090, Austria.
³ Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
⁴ Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN 55905, USA.

PMID: 37464750
DOI: 10.4155/tde-2023-0014

Abstract

Tweetable abstract Emerging targeted therapies offer hope for malignant peripheral nerve sheath tumor. Innovative drug delivery enhances potential treatments. #MPNST #TargetedTherapies #TherapeuticDelivery.

Keywords: MPNST; drug delivery; intratumoral administration; malignant peripheral nerve sheath tumor; targeted therapy.

MeSH terms

Drug Delivery Systems
Humans
Nerve Sheath Neoplasms* / drug therapy
Nerve Sheath Neoplasms* / pathology
Neurofibrosarcoma*